India's RPG Life Sciences falls on Q2 profit slump
** Shares of RPG Life Sciences RPGL.NS fall 5.3% to
2,511.95 rupees, set for worst day in two weeks
** Pharma co reports an 84% fall in Sept-qtr profit at 42
million rupees ($497,763.03); rev from ops up 12%
** Busiest session since mid Oct.; more than 48,000 shares
change hands
** Stock up ~88% so far this year, on track for sixth
straight year of gains
($1 = 84.3775 Indian rupees)
(Reporting by Dimpal Gulwani in Bengaluru)
((dimpal.gulwani@thomsonreuters.com))
Recent news on RPG Life Sciences
See all newsBrief: RPG Life Sciences June-Quarter Consol Profit 307.6 Million Rupees
Brief: RPG Life Sciences Partners With Archerchem Healthcare For Naprosyn ES Launch
Brief: RPG Life Sciences March-Quarter Consol Profit 299 Million Rupees
India's RPG Life Sciences hits 9-month low on quarterly profit fall
Brief: RPG Life Sciences Dec-Quarter Consol Profit 221.3 Million Rupees